Compare ADV & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ADV | EMBC |
|---|---|---|
| Founded | 1987 | 1924 |
| Country | United States | United States |
| Employees | 73000 | N/A |
| Industry | Business Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 438.2M | 524.1M |
| IPO Year | N/A | 2021 |
| Metric | ADV | EMBC |
|---|---|---|
| Price | $38.02 | $3.35 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 2 |
| Target Price | ★ $45.83 | $18.50 |
| AVG Volume (30 Days) | 83.7K | ★ 3.6M |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 6.88% |
| EPS Growth | N/A | ★ 20.90 |
| EPS | N/A | ★ 0.67 |
| Revenue | N/A | N/A |
| Revenue This Year | $0.63 | $1.17 |
| Revenue Next Year | $0.45 | N/A |
| P/E Ratio | ★ N/A | $4.96 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.49 | $2.77 |
| 52 Week High | $46.80 | $15.55 |
| Indicator | ADV | EMBC |
|---|---|---|
| Relative Strength Index (RSI) | 55.07 | 24.66 |
| Support Level | $1.00 | $2.77 |
| Resistance Level | $46.80 | $9.38 |
| Average True Range (ATR) | 3.42 | 0.23 |
| MACD | -0.53 | 0.17 |
| Stochastic Oscillator | 48.13 | 62.50 |
Advantage Solutions Inc provides outsourced sales, marketing, merchandising, sampling, and retailer support services to consumer packaged goods manufacturers and retailers across North America. Its services are designed to support distribution, retail execution, shopper engagement, and private brand development across both physical and digital commerce environments. The company serves various clients across grocery, mass, club, retail pharmacy, convenience, and other channels. It operates through three reportable segments: Branded Services, Experiential Services, and Retailer Services. The majority of the revenue is derived from the Experiential Services segment, which provides in-store and digital sampling programs, demonstrations, and experiential events for manufacturers and retailers.
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.